{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:42:45Z","timestamp":1758588165974,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.transproceed.2022.07.005","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T02:13:48Z","timestamp":1663294428000},"page":"2133-2139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Thymoglobulin and Grafalon as Induction Agents in Renal Transplantation: A Prospective Study"],"prefix":"10.1016","volume":"54","author":[{"given":"Sharmila","family":"Thukral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratnesh","family":"Rokde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6775-7321","authenticated-orcid":false,"given":"Deepak Shankar","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.07.005_bib0001","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/j.ajkd.2009.06.020","article-title":"Induction antibody therapy in kidney transplantation","volume":"54","author":"Padiyar","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0002","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/01.TP.0000116442.81259.60","article-title":"Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study","volume":"77","author":"Ducloux","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0003","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.amjsurg.2008.04.025","article-title":"New directions for induction immunosuppression strategy in solid organ transplantation","volume":"197","author":"Hawksworth","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0004","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/TP.0b013e31816dd596","article-title":"Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients","volume":"85","author":"Gurk-Turner","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0005","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/TP.0b013e31825c58c0","article-title":"Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients:6-month outcomes","volume":"94","author":"Trofe-Clark","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0006","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood.V79.8.2164.2164","article-title":"Antiproliferative effect of antilymphocyte globulins on B cells and B-cell lines","volume":"79","author":"Bonnefoy-Berard","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0007","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1111\/ajt.12514","article-title":"A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations","volume":"13","author":"Popow","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0008","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/00007890-199504270-00020","article-title":"Comparative polyclonal antithymocyte globulin and antilymphocyte\/antilymphoblast globulin anti-CD antigen analysis by flow cytometry","volume":"59","author":"Bourdage","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0009","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/00007890-199711270-00010","article-title":"Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies","volume":"64","author":"M\u00fcller","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1155\/2015\/980924","article-title":"Comparing two types of rabbit ATG prior to reduced intensity conditioning allogeneic hematopoietic SCT for hematologic malignancies","volume":"2015","author":"Paiano","year":"2015","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0011","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1182\/blood-2011-01-332007","article-title":"Impact of immune modulation with anti\u2013T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies","volume":"117","author":"Soiffer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0012","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1097\/00007890-200005150-00026","article-title":"Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines","volume":"69","author":"Zuckermann","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0013","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/S0041-1345(97)00813-0","article-title":"A randomized clinical trial using ATG Fresenius or ATG Merieux as induction therapy in kidney transplantation","volume":"29","author":"Norrby","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0014","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/S0041-1345(97)00433-8","article-title":"A prospective study on efficacy and tolerance of antithymocyte globulin Fresenius versus thymoglobuline Merieux after renal transplantation","volume":"29","author":"Ourahma","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fimmu.2020.00457","article-title":"Thymoglobulin vs. ATG-Fresenius as induction therapy in kidney transplantation: a bayesian network meta-analysis of randomized controlled trials","volume":"11","author":"Song","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.trim.2017.09.002","article-title":"Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulins","volume":"45","author":"Bamoulid","year":"2017","journal-title":"Transplant Immunol"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0017","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0041-1345(98)00269-3","article-title":"Low incidence of acute rejection in kidney grafts treated with initial quadruple therapy: a retrospective analysis comparing two ATGs","volume":"30","author":"Civati","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.07.005_bib0018","doi-asserted-by":"crossref","first-page":"418","DOI":"10.6002\/ect.2013.0027","article-title":"Clinical experience with thymoglobulin and antithymocyte globulin-Fresenius as induction therapy in renal transplant patients: a retrospective study","volume":"11","author":"Cicora","year":"2013","journal-title":"Exp Clin Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522004985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522004985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:42:51Z","timestamp":1758577371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134522004985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0041134522004985"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.07.005","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Thymoglobulin and Grafalon as Induction Agents in Renal Transplantation: A Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}